Akums Drugs

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE09XN01023
  • NSEID: AKUMS
  • BSEID: 544222
INR
696.05
-16.3 (-2.29%)
BSENSE

Nov 20

BSE+NSE Vol: 1.59 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
1,342.39
1,166.63
1,157.87
1,159.59
1,017.53
1,024.03
1,055.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,342.39
1,166.63
1,157.87
1,159.59
1,017.53
1,024.03
1,055.55
Raw Material Cost
719.46
682.12
586.91
611.26
552.63
547.90
623.85
Purchase of Finished goods
50.52
26.49
62.93
60.29
56.71
21.08
19.49
(Increase) / Decrease In Stocks
-3.26
-63.19
10.63
7.04
-16.77
12.94
-4.25
Employee Cost
224.27
201.43
199.03
189.38
189.27
176.14
183.90
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
-0.01
-0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
156.68
145.10
146.66
144.77
141.23
137.00
138.64
Total Expenditure (Excl Depreciation)
1,147.66
991.95
1,006.15
1,012.73
923.06
895.06
961.63
Operating Profit (PBDIT) excl Other Income
194.73
174.68
151.72
146.86
94.47
128.97
93.92
Other Income
28.91
30.38
35.30
34.33
32.37
26.73
17.55
Operating Profit (PBDIT)
223.64
205.06
187.02
181.19
126.84
155.70
111.47
Interest
25.68
24.76
23.89
23.74
23.30
23.14
4.54
Exceptional Items
0.00
0.00
-1.80
-18.23
0.00
0.00
8.22
Gross Profit (PBDT)
197.96
180.30
161.33
139.22
103.54
132.56
115.15
Depreciation
43.21
41.07
40.12
39.65
37.86
36.92
40.00
Profit Before Tax
154.74
139.24
121.22
99.57
65.67
95.65
75.14
Tax
40.18
38.26
39.87
31.89
22.98
30.96
-74.47
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
114.57
100.98
81.34
67.67
42.70
64.69
149.61
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
114.57
100.98
81.34
67.67
42.70
64.69
149.61
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.71
0.97
-3.27
1.36
1.91
1.21
1.99
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
112.85
100.01
84.61
66.32
40.78
63.48
147.62
Equity Capital
30.62
30.62
30.62
30.62
30.62
30.62
30.62
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
7.37
6.53
5.53
4.33
2.66
4.15
9.64
Diluted Earnings per share
7.37
6.53
5.53
4.33
2.66
4.15
9.64
Operating Profit Margin (Excl OI)
14.51%
14.97%
13.1%
12.66%
9.28%
12.59%
8.9%
Gross Profit Margin
14.75%
15.45%
13.93%
12.01%
10.18%
12.94%
10.91%
PAT Margin
8.53%
8.66%
7.02%
5.84%
4.2%
6.32%
14.17%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 15.07% vs 0.76% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 12.84% vs 18.20% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 11.48% vs 15.13% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 3.72% vs 3.64% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Akums Drugs With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,342.39
309.07
1,033.32
334.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,342.39
309.07
1,033.32
334.33%
Raw Material Cost
719.46
63.66
655.80
1,030.16%
Purchase of Finished goods
50.52
16.24
34.28
211.08%
(Increase) / Decrease In Stocks
-3.26
-6.35
3.09
48.66%
Employee Cost
224.27
52.31
171.96
328.73%
Power Cost
0.00
36.64
-36.64
-100.00%
Manufacturing Expenses
-0.01
0.01
-0.02
-200.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
156.68
42.18
114.50
271.46%
Total Expenditure (Excl Depreciation)
1,147.66
204.69
942.97
460.68%
Operating Profit (PBDIT) excl Other Income
194.73
104.38
90.35
86.56%
Other Income
28.91
10.17
18.74
184.27%
Operating Profit (PBDIT)
223.64
114.55
109.09
95.23%
Interest
25.68
0.03
25.65
85,500.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
197.96
114.52
83.44
72.86%
Depreciation
43.21
18.38
24.83
135.09%
Profit Before Tax
154.74
95.48
59.26
62.07%
Tax
40.18
25.91
14.27
55.08%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
114.57
70.23
44.34
63.14%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
114.57
70.23
44.34
63.14%
Share in Profit of Associates
0.00
-0.66
0.66
100.00%
Minority Interest
1.71
-1.08
2.79
258.33%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
112.85
70.65
42.20
59.73%
Equity Capital
30.62
10.46
20.16
192.73%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.37
6.75
0.62
9.19%
Diluted Earnings per share
7.37
6.65
0.72
10.83%
Operating Profit Margin (Excl OI)
14.51%
33.77%
0.00
-19.26%
Gross Profit Margin
14.75%
37.05%
0.00
-22.30%
PAT Margin
8.53%
22.51%
0.00
-13.98%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,342.39 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 15.07% vs 0.76% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 31.93% vs -1.51% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 112.85 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 12.84% vs 18.20% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 176.73% vs -37.46% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 194.73 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 11.48% vs 15.13% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 106.13% vs -22.05% in Sep 2025

Quarterly - Interest
Interest 25.68 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 3.72% vs 3.64% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 10.21% vs 95.80% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.51%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025